Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "RIL"

1109 News Found

Approx 800 million Indians do not have health coverage, says Expert
Healthcare | April 06, 2023

Approx 800 million Indians do not have health coverage, says Expert

Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand


India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting
Policy | April 05, 2023

India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting

Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted


Top management changes at IOL Chemicals and Pharmaceuticals
People | April 04, 2023

Top management changes at IOL Chemicals and Pharmaceuticals

Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company


GSK and SCYNEXIS announce agreement to commercialise and further develop Brexafemme
News | April 03, 2023

GSK and SCYNEXIS announce agreement to commercialise and further develop Brexafemme

SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties


EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
News | April 03, 2023

EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company

EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging


Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer
Diagnostic Center | April 03, 2023

Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer

Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations


Lonza completes drug product manufacturing line in Visp
News | March 31, 2023

Lonza completes drug product manufacturing line in Visp

This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering


Abberior installs STED Microscope at MBC BioLabs
News | March 31, 2023

Abberior installs STED Microscope at MBC BioLabs

Stedycon Sted super-resolution fluorescence microscope


MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine
News | March 30, 2023

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers


Govt. reviews public health preparedness for management of COVID-19
Public Health | March 28, 2023

Govt. reviews public health preparedness for management of COVID-19

States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources